Showing 1 - 10 results of 10 for search 'Jeffrey D. Bradley', query time: 0.05s
Refine Results
-
1
-
2
-
3
Review of Machine Learning in Lung Ultrasound in COVID-19 Pandemic by Jing Wang, Xiaofeng Yang, Boran Zhou, James J. Sohn, Jun Zhou, Jesse T. Jacob, Kristin A. Higgins, Jeffrey D. Bradley, Tian Liu
Published 2022-03-01
Article -
4
Single energy CT-based mass density and relative stopping power estimation for proton therapy using deep learning method by Yuan Gao, Chih-Wei Chang, Justin Roper, Marian Axente, Yang Lei, Shaoyan Pan, Jeffrey D. Bradley, Jun Zhou, Tian Liu, Tian Liu, Xiaofeng Yang, Xiaofeng Yang
Published 2023-11-01
Article -
5
A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma by Gregory Vlacich, Andrew Ballard, Shahed N. Badiyan, Matthew Spraker, Lauren Henke, Hyun Kim, A. Craig Lockhart, Haeseong Park, Rama Suresh, Yi Huang, Cliff G. Robinson, Jeffrey D. Bradley, Pamela P. Samson
Published 2021-09-01
Article -
6
NRG Oncology Survey of Monte Carlo Dose Calculation Use in US Proton Therapy Centers by Liyong Lin, PhD, Paige A. Taylor, MS, Jiajian Shen, PhD, Jatinder Saini, PhD, Minglei Kang, PhD, Charles B. Simone, II, MD, Jeffrey D. Bradley, MD, Zuofeng Li, DSc, Ying Xiao, PhD
Published 2021-05-01
Article -
7
Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era by James R. Janopaul-Naylor, Yichun Cao, Neal S. McCall, Jeffrey M. Switchenko, Jeffrey M. Switchenko, Sibo Tian, Haijian Chen, William A. Stokes, Aparna H. Kesarwala, Mark W. McDonald, Joseph W. Shelton, Jeffrey D. Bradley, Kristin A. Higgins
Published 2023-01-01
Article -
8
Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617 by Jian-Yue Jin, Chen Hu, Ying Xiao, Hong Zhang, Rebecca Paulus, Susannah G. Ellsworth, Steven E. Schild, Jeffrey A. Bogart, Michael Chris Dobelbower, Vivek S. Kavadi, Samir Narayan, Puneeth Iyengar, Cliff Robinson, Joel S. Greenberger, Christopher Koprowski, Mitchell Machtay, Walter Curran, Hak Choy, Jeffrey D. Bradley, Feng-Ming (Spring) Kong
Published 2021-12-01
Article -
9
Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400... by Roy S Herbst, Naiyer Rizvi, Karen Kelly, Vassiliki A Papadimitrakopoulou, Natasha B Leighl, Mary W Redman, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, James L Wade, William J Irvin, Sreekanth C Reddy, Jeffrey Crawford, Jeffrey D Bradley, Thomas E Stinchcombe, Suresh S Ramalingam, Jieling Miao, Katherine Minichiello, David R Gandara
Published 2021-08-01
Article -
10
Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system by Benjamin W. Fischer-Valuck, MD, Lauren Henke, MD, Olga Green, PhD, Rojano Kashani, PhD, Sahaja Acharya, MD, Jeffrey D. Bradley, MD, Clifford G. Robinson, MD, Maria Thomas, MD, PhD, Imran Zoberi, MD, Wade Thorstad, MD, Hiram Gay, MD, Jiayi Huang, MD, Michael Roach, MD, Vivian Rodriguez, PhD, Lakshmi Santanam, PhD, Harold Li, PhD, Hua Li, PhD, Jessika Contreras, MD, Thomas Mazur, PhD, Dennis Hallahan, MD, Jeffrey R. Olsen, MD, Parag Parikh, MD, Sasa Mutic, PhD, Jeff Michalski, MD, MBA
Published 2017-07-01
Article